Stocks and Investing
Stocks and Investing
Thu, May 18, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
William Plovanic Maintained (TMDX) at Strong Buy with Decreased Target to $86 on, May 18th, 2023
William Plovanic of Canaccord Genuity, Maintained "TransMedics Group, Inc." (TMDX) at Strong Buy with Decreased Target from $91 to $86 on, May 18th, 2023.
William has made no other calls on TMDX in the last 4 months.
There are 4 other peers that have a rating on TMDX. Out of the 4 peers that are also analyzing TMDX, 1 agrees with William's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Cecilia Furlong of "Morgan Stanley" Maintained at Hold with Increased Target to $81 on, Wednesday, May 3rd, 2023
These are the ratings of the 3 analyists that currently disagree with William
- Suraj Kalia of "Oppenheimer" Maintained at Buy with Increased Target to $90 on, Tuesday, May 2nd, 2023
- Thomas Allen of "JP Morgan" Maintained at Buy with Increased Target to $81 on, Thursday, February 23rd, 2023
- Joshua Jennings of "Cowen & Co." Maintained at Buy with Increased Target to $75 on, Thursday, February 23rd, 2023
Contributing Sources